Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 10/20 | 0.50 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | PAK1 | Q13153 | 2/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10001934 | 0.93 | TERT (0.49) | TERTTNKS2TSHRPAK1RAB9A | |
| SCHEMBL10035606 | 0.86 | TERT (0.52) | TERTTNKS2TSHRPAK1NPY5R | |
| SCHEMBL10035654 | 0.83 | TERT (0.55) | TERTTNKS2TSHRRAB9AALDH1A1 | |
| SCHEMBL10035702 | 0.82 | TERT (0.39) | TERTALDH1A1CYP2C9HPGD | |
| SCHEMBL10001927 | 0.82 | TERT (0.40) | TERT | |
| SCHEMBL10035653 | 0.82 | TERT (0.54) | TERTTNKS2TSHRPAK1RAB9A | |
| SCHEMBL10001931 | 0.79 | TERT (0.51) | TERTTNKS2TSHRPAK1RAB9A | |
| SCHEMBL10001921 | 0.77 | TERT (0.48) | TERTTNKS2TSHRALDH1A1ALOX15 | |
| SCHEMBL10001924 | 0.77 | TERT (0.41) | TERTTNKS2TSHRPAK1RAB9A | |
| SCHEMBL10001935 | 0.76 | TERT (0.47) | TERTTNKS2TSHRPAK1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8110404-B2 | Luminescent lanthanide binding chelates | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2012-02-07 | — | — | US | disclosed |
| US-20080299675-A1 | Luminescent Lanthanide Binding Chelates | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080299675-A1 | Luminescent Lanthanide Binding Chelates | HLCS, LYAR, SLC6A13 | TERT 2908/4885TNKS2 3224/4885TSHR 512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.